Tag: pharmacovigilance market trends

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Pharmacovigilance Market Through 2034?

In recent times, there has been a notable rapid expansion in the pharmacovigilance market. Forecasts suggest an increase from $8.58 billion in 2024 to $9.64 billion in 2025, equating to a compound annual growth rate (CAGR) of 12.4%. The significant growth witnessed during the historic period owes to factors such as the rising cases of adverse drug reactions (ADRs), escalation in research and development initiatives, an upsurge in drug development rates, increased attention towards personalized medicine, and a growing occurrence of chronic diseases.

The market for pharmacovigilance is predicted to grow swiftly in the coming years with a projected valuation of $15.5 billion in 2029, corresponding to a compound annual growth rate (CAGR) of 12.6%. The projected growth during the forecast timeframe can be ascribed to factors such as rising healthcare costs, enhanced government backing, and an aging population. Key trends for the forecast period comprise rising investments, the application of artificial intelligence, the integration of innovative platforms and cutting-edge cloud-based systems, along with strategic mergers and acquisitions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp

What Are the Core Growth Drivers Propelling the Pharmacovigilance Market Forward?

The pharmacovigilance market is being propelled forward by an increase in research and development initiatives. The creation of innovative and improved safety-profile drugs can be accomplished through investment in R&D by pharmaceutical firms. During the drug development procedure, rigorous preclinical and clinical tests enable early recognition of potential safety hazards, which paves the way for effective risk management strategies. Furthermore, advancements in technologies for monitoring adverse events, data analysis, and signal detection are facilitated by R&D activities, leading to earlier recognition of adverse drug reactions in the post-marketing stage. For example, in February 2024, the Llywodraeth Cymru Welsh Government, a government institution based in the UK, stated that in 2022, Wales devoted £1.0 billion ($1.25 billion) to Business Expenditure on Research and Development (BERD), making up 1.9% of the UK’s total spending in this field. As a result, the pharmacovigilance market was bolstered by expanding research and development initiatives.

What Segment Types Define the Pharmacovigilance Market Structure?

The pharmacovigilance market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining

2) By Service Provider: In-House, Contract Outsourcing

3) By Process Flow: Case Data Management, Signal Detection, Risk Management System

4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV

5) By End User: Hospitals, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals

2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies

3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs

4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies

5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=5928&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Pharmacovigilance Market?

North America was the largest region in the pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing thePharmacovigilance Industry Evolution?

Pharmacovigilance market players are leveraging artificial intelligence (AI) to enhance their operational efficiency. The use of AI in pharmacovigilance boosts the accuracy and effectiveness of activities associated with pharmacovigilance, leading to improved patient results. Employing AI allows pharmaceutical firms to facilitate their procedures, enhance the handling of data, and expedite the drug discovery process. It also aids in decreasing expenses and uplifting safety measures. For example, the Indian Government in August 2024, unveiled the Adverse Drug Reaction Monitoring System (ADRMS) software, initiated by the Minister of Health & Family Welfare and the Minister of Chemicals and Fertilizers. This specialized pharmacovigilance software aids in collecting and scrutinizing adverse events related to drugs and medical equipment, thereby simplifying the reporting process for consumers and healthcare professionals alike. This move significantly upgrades India’s pharmacovigilance framework by enabling a comprehensive acquisition of safety data and boosting the monitoring of drug safety. The core objective of the ADRMS is to augment the effectiveness of drug safety surveillance and adherence to standards, thereby solidifying India’s position as a frontrunner in the worldwide pharmaceutical sector.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

What Is the Definition of the Pharmacovigilance Market?

Pharmacovigilance refers to the science and practices involved in the identification, evaluation, comprehension, and mitigation of side effects and other medical/vaccination-related issues. It is used to determine whether a drug’s advantages outweigh its hazards, and it doesn’t end once the drugs are approved.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5928

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Pharmacovigilance Market Through 2034?

In recent times, there has been a notable rapid expansion in the pharmacovigilance market. Forecasts suggest an increase from $8.58 billion in 2024 to $9.64 billion in 2025, equating to a compound annual growth rate (CAGR) of 12.4%. The significant growth witnessed during the historic period owes to factors such as the rising cases of adverse drug reactions (ADRs), escalation in research and development initiatives, an upsurge in drug development rates, increased attention towards personalized medicine, and a growing occurrence of chronic diseases.

The market for pharmacovigilance is predicted to grow swiftly in the coming years with a projected valuation of $15.5 billion in 2029, corresponding to a compound annual growth rate (CAGR) of 12.6%. The projected growth during the forecast timeframe can be ascribed to factors such as rising healthcare costs, enhanced government backing, and an aging population. Key trends for the forecast period comprise rising investments, the application of artificial intelligence, the integration of innovative platforms and cutting-edge cloud-based systems, along with strategic mergers and acquisitions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp

What Are the Core Growth Drivers Propelling the Pharmacovigilance Market Forward?

The pharmacovigilance market is being propelled forward by an increase in research and development initiatives. The creation of innovative and improved safety-profile drugs can be accomplished through investment in R&D by pharmaceutical firms. During the drug development procedure, rigorous preclinical and clinical tests enable early recognition of potential safety hazards, which paves the way for effective risk management strategies. Furthermore, advancements in technologies for monitoring adverse events, data analysis, and signal detection are facilitated by R&D activities, leading to earlier recognition of adverse drug reactions in the post-marketing stage. For example, in February 2024, the Llywodraeth Cymru Welsh Government, a government institution based in the UK, stated that in 2022, Wales devoted £1.0 billion ($1.25 billion) to Business Expenditure on Research and Development (BERD), making up 1.9% of the UK’s total spending in this field. As a result, the pharmacovigilance market was bolstered by expanding research and development initiatives.

What Segment Types Define the Pharmacovigilance Market Structure?

The pharmacovigilance market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining

2) By Service Provider: In-House, Contract Outsourcing

3) By Process Flow: Case Data Management, Signal Detection, Risk Management System

4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV

5) By End User: Hospitals, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals

2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies

3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs

4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies

5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=5928&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Pharmacovigilance Market?

North America was the largest region in the pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing thePharmacovigilance Industry Evolution?

Pharmacovigilance market players are leveraging artificial intelligence (AI) to enhance their operational efficiency. The use of AI in pharmacovigilance boosts the accuracy and effectiveness of activities associated with pharmacovigilance, leading to improved patient results. Employing AI allows pharmaceutical firms to facilitate their procedures, enhance the handling of data, and expedite the drug discovery process. It also aids in decreasing expenses and uplifting safety measures. For example, the Indian Government in August 2024, unveiled the Adverse Drug Reaction Monitoring System (ADRMS) software, initiated by the Minister of Health & Family Welfare and the Minister of Chemicals and Fertilizers. This specialized pharmacovigilance software aids in collecting and scrutinizing adverse events related to drugs and medical equipment, thereby simplifying the reporting process for consumers and healthcare professionals alike. This move significantly upgrades India’s pharmacovigilance framework by enabling a comprehensive acquisition of safety data and boosting the monitoring of drug safety. The core objective of the ADRMS is to augment the effectiveness of drug safety surveillance and adherence to standards, thereby solidifying India’s position as a frontrunner in the worldwide pharmaceutical sector.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

What Is the Definition of the Pharmacovigilance Market?

Pharmacovigilance refers to the science and practices involved in the identification, evaluation, comprehension, and mitigation of side effects and other medical/vaccination-related issues. It is used to determine whether a drug’s advantages outweigh its hazards, and it doesn’t end once the drugs are approved.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5928

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#What Is the Current and Projected Market Size of the Pharmacovigilance Market Through 2034?#_x000D_

In recent times, there has been a notable rapid expansion in the pharmacovigilance market. Forecasts suggest an increase from $8.58 billion in 2024 to $9.64 billion in 2025, equating to a compound annual growth rate (CAGR) of 12.4%. The significant growth witnessed during the historic period owes to factors such as the rising cases of adverse drug reactions (ADRs), escalation in research and development initiatives, an upsurge in drug development rates, increased attention towards personalized medicine, and a growing occurrence of chronic diseases._x000D_

_x000D_

The market for pharmacovigilance is predicted to grow swiftly in the coming years with a projected valuation of $15.5 billion in 2029, corresponding to a compound annual growth rate (CAGR) of 12.6%. The projected growth during the forecast timeframe can be ascribed to factors such as rising healthcare costs, enhanced government backing, and an aging population. Key trends for the forecast period comprise rising investments, the application of artificial intelligence, the integration of innovative platforms and cutting-edge cloud-based systems, along with strategic mergers and acquisitions._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp_x000D_

_x000D_

#What Are the Core Growth Drivers Propelling the Pharmacovigilance Market Forward?#_x000D_

The pharmacovigilance market is being propelled forward by an increase in research and development initiatives. The creation of innovative and improved safety-profile drugs can be accomplished through investment in R&D by pharmaceutical firms. During the drug development procedure, rigorous preclinical and clinical tests enable early recognition of potential safety hazards, which paves the way for effective risk management strategies. Furthermore, advancements in technologies for monitoring adverse events, data analysis, and signal detection are facilitated by R&D activities, leading to earlier recognition of adverse drug reactions in the post-marketing stage. For example, in February 2024, the Llywodraeth Cymru Welsh Government, a government institution based in the UK, stated that in 2022, Wales devoted £1.0 billion ($1.25 billion) to Business Expenditure on Research and Development (BERD), making up 1.9% of the UK’s total spending in this field. As a result, the pharmacovigilance market was bolstered by expanding research and development initiatives._x000D_

_x000D_

#What Segment Types Define the Pharmacovigilance Market Structure?#_x000D_

The pharmacovigilance market covered in this report is segmented – _x000D_

_x000D_

1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining_x000D_

2) By Service Provider: In-House, Contract Outsourcing_x000D_

3) By Process Flow: Case Data Management, Signal Detection, Risk Management System_x000D_

4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV_x000D_

5) By End User: Hospitals, Pharmaceutical Companies, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals _x000D_

2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies _x000D_

3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs _x000D_

4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies _x000D_

5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems _x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=5928&type=smp_x000D_

_x000D_

#Which Geographic Areas Hold the Strongest Growth Potential in the Pharmacovigilance Market?#_x000D_

North America was the largest region in the pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Which Emerging Trends that Are Influencing thePharmacovigilance Industry Evolution?#_x000D_

Pharmacovigilance market players are leveraging artificial intelligence (AI) to enhance their operational efficiency. The use of AI in pharmacovigilance boosts the accuracy and effectiveness of activities associated with pharmacovigilance, leading to improved patient results. Employing AI allows pharmaceutical firms to facilitate their procedures, enhance the handling of data, and expedite the drug discovery process. It also aids in decreasing expenses and uplifting safety measures. For example, the Indian Government in August 2024, unveiled the Adverse Drug Reaction Monitoring System (ADRMS) software, initiated by the Minister of Health & Family Welfare and the Minister of Chemicals and Fertilizers. This specialized pharmacovigilance software aids in collecting and scrutinizing adverse events related to drugs and medical equipment, thereby simplifying the reporting process for consumers and healthcare professionals alike. This move significantly upgrades India’s pharmacovigilance framework by enabling a comprehensive acquisition of safety data and boosting the monitoring of drug safety. The core objective of the ADRMS is to augment the effectiveness of drug safety surveillance and adherence to standards, thereby solidifying India’s position as a frontrunner in the worldwide pharmaceutical sector._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report_x000D_

_x000D_

#What Is the Definition of the Pharmacovigilance Market?#_x000D_

Pharmacovigilance refers to the science and practices involved in the identification, evaluation, comprehension, and mitigation of side effects and other medical/vaccination-related issues. It is used to determine whether a drug’s advantages outweigh its hazards, and it doesn’t end once the drugs are approved._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5928_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Pharmacovigilance Market from 2024 to 2025?

In recent times, there has been a significant expansion in the size of the pharmacovigilance market. The projected growth sees it rising from $8.58 billion in 2024 to an astounding $9.73 billion in 2025, fueled by a compound annual growth rate (CAGR) of 13.5%. Several factors have contributed to this growth during the historic period, including an increase in the incidents of adverse drug reactions (ADRs), enhanced research and development (R&D) activities, escalated drug development rates, an amplified emphasis on personalized medicine, and the escalating incidence of chronic diseases.

What Is the Projected Market Size of the Pharmacovigilance Market?

In the coming years, the pharmacovigilance market size is predicted to witness significant expansion, reaching $15.83 billion by 2029 with a compound annual growth rate (CAGR) of 12.9%. This growth during the forecast period can be ascribed to factors such as escalating healthcare costs, augmented government aid, and an aging demographic. The forecast period will also observe major trends like increased investments, the application of artificial intelligence, the utilization of novel platforms and innovative cloud-based systems, as well as strategic mergers and acquisitions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp

Who are the Major Competitors in the Pharmacovigilance Market Outlook?

Major companies operating in the pharmacovigilance market include IQVIA, Cognizant, ICON Plc, Accenture plc, PAREXEL International Corporation., United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, Wuxi Apptec, Simcere Pharmaceutical Group, Lee’s Pharmaceutical Holdings, Luye Pharma Group, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Alcon, Secure AI Labs, OmniSol dot Tech, Canna Call Company, Veripad, Prevnos Inc., Lifescient, Inc, BeiGene, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., MSD, Novasyte, Fortrea Holdings Inc, Syneos Health Clinical, Zoetis Inc., Telerx Marketing Inc., Gilead Sciences, Inc., Elanco, Abbott Laboratories, Spimaco, Teva Pharmaceutical Industries Ltd.

What Is Fueling Growth in the Pharmacovigilance Market?

The surge in research and development activities is a major factor fuelling the growth of the pharmacovigilance market. By putting funds into R&D, companies in the pharmaceutical industry have the capacity to produce novel, innovative drugs with enhanced safety profiles. Thorough preclinical and clinical trials during the drug development phase allow for early recognition of potential safety issues, enabling relevant risk mitigation strategies. Moreover, R&D initiatives contribute to the progression of technologies for monitoring adverse events, data evaluation, and signal detection, assisting in the early identification of negative drug reactions during the post-marketing phase. For example, the Llywodraeth Cymru Welsh Government, a governmental agency based in the UK, announced in February 2024 that Wales allocated £1.0 billion ($1.25 billion) to Business Expenditure on Research and Development (BERD) in 2022, equating to 1.9% of the total UK spending in this sector. Thus, escalating research and development activities have strongly backed the expansion of the pharmacovigilance market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=5928&type=smp

Which Pharmacovigilance Market Segments Are Growing the Fastest?

The pharmacovigilance market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining

2) By Service Provider: In-House, Contract Outsourcing

3) By Process Flow: Case Data Management, Signal Detection, Risk Management System

4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV

5) By End User: Hospitals, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals

2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies

3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs

4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies

5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems

Which Industry Trends Are Shaping the Future of the Pharmacovigilance Market?

Firms operating in the pharmacovigilance market are progressively leveraging artificial intelligence (AI) to enhance functional efficiency. AI can significantly improve the precision and efficiency of pharmacovigilance operations, ultimately improving patient results. By implementing AI, pharmaceutical corporations can streamline their workflows, enhance data management, accelerate drug innovations, and concurrently decrease expenses while enhancing safety measures. For instance, in August 2024, the Indian Government unveiled the Adverse Drug Reaction Monitoring System (ADRMS) software, announced by the Minister of Health & Family Welfare and Minister of Chemicals and Fertilizers. This pharmacovigilance software aids in gathering and scrutinizing adverse incidents related to drugs and medical equipment, simplifying the reporting process for consumers and healthcare experts. This initiative considerably reinforces India’s pharmacovigilance framework by guaranteeing a more inclusive grasp of safety data and promoting drug safety monitoring. The ADRMS aspires to augment the efficacy of drug safety oversight and adherence to standards, aiding India’s ambition to spearhead the global pharmaceutical sector.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

Which Countries Are Leading the Pharmacovigilance Market?

North America was the largest region in the pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5928

This Report Delivers Insight On:

1. How big is the pharmacovigilance market, and how is it changing globally?

2. Who are the major companies in the pharmacovigilance market, and how are they performing?

3. What are the key opportunities and risks in the pharmacovigilance market right now?

4. Which products or customer segments are growing the most in the pharmacovigilance market?

5. What factors are helping or slowing down the growth of the pharmacovigilance market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the pharmacovigilance industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Estimated Market Size of the Pharmacovigilance Market In 2029?

In the past few years, there has been a significant expansion in the pharmacovigilance market size. The market is projected to escalate from a worth of $8.58 billion in 2024 to a staggering $9.73 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 13.5%. This growth during the historical period is primarily due to the heightened occurrence of adverse drug reactions (ADRs), increased research and development (R&D) operations, surging rate of drug development, an intensified focus on personalized medicine, and a climbing prevalence of chronic ailments.

In the coming years, the pharmacovigilance market is predicted to experience substantial expansion, reaching an estimated worth of $15.83 billion by 2029, at a compound annual growth rate (CAGR) of 12.9%. Factors contributing to this growth phase within the forecast period include an escalation in healthcare spending, enhanced government backing, and an aging demographic. Ascending trends projected within this span involve heightened investments, the integration of artificial intelligence, the adoption of inventive platforms and innovative cloud-based systems, and strategic partnering through mergers and acquisitions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp

Which Factors and External Forces Are Driving Demand in the Pharmacovigilance Market?

The pharmacovigilance market is propelled forward by heightened research and development ventures. The production of new and inventive medications with enhanced safety profiles becomes possible through substantial investments in R&D by pharmaceutical firms. In-depth preclinical and clinical examinations during the developmental stages of drugs also play a part in recognizing potential safety issues early on, enabling the application of effective risk management practices. In addition to this, R&D initiatives further the progression of technologies meant for monitoring adverse events, analyzing data, and detecting signals. This leads to the early identification of adverse reactions to drugs in the post-marketing period. A case in point is when Llywodraeth Cymru Welsh Government, a UK-based government entity, reported in February 2024 that in 2022, Wales invested £1.0 billion ($1.25 billion) in Business Expenditure on Research and Development (BERD), comprising 1.9% of the UK’s total expenditure in this sector. Consequently, the ascent in research and development endeavors has played a significant role in boosting the pharmacovigilance market.

Which Segments in the Pharmacovigilance Offer the Most Growth?

The pharmacovigilance market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining

2) By Service Provider: In-House, Contract Outsourcing

3) By Process Flow: Case Data Management, Signal Detection, Risk Management System

4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV

5) By End User: Hospitals, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals

2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies

3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs

4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies

5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=5928&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Pharmacovigilance Market?# Market?

North America was the largest region in the pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive thePharmacovigilance Market’s Growth?

Firms operating in the pharmacovigilance industry are leveraging the power of artificial intelligence (AI) to boost efficiency. By embracing AI, such companies can enhance the precision and efficacy of their pharmacovigilance efforts which in turn can lead to improved patient outcomes. AI makes it possible for pharmaceutical firms to expedite their processes, refine their data management endeavors, and quicken drug discovery, all the while cutting costs and raising safety. For instance, the Indian Government introduced the Adverse Drug Reaction Monitoring System (ADRMS) software in August 2024. This pharmacovigilance tool was unveiled by the Minister of Health & Family Welfare along with the Minister of Chemicals and Fertilizers. Employing this software allows for efficient collection and scrutiny of adverse events linked to medications and medical devices. Therefore, easing the reporting procedure for both consumers and medical professionals alike. This move has significantly bolstered India’s pharmacovigilance infrastructure assuring a wider collection of safety data and improving drug safety observation. The ADRMS has been designed to elevate the efficiency of drug safety regulation and adherence to standards, which reinforces India’s position as a major player in the international pharmaceutical arena.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

What Are the Key Elements That Define the Pharmacovigilance Market?

Pharmacovigilance refers to the science and practices involved in the identification, evaluation, comprehension, and mitigation of side effects and other medical/vaccination-related issues. It is used to determine whether a drug’s advantages outweigh its hazards, and it doesn’t end once the drugs are approved.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5928

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Pharmacovigilance Market?

Boosting research and development tasks will contribute to the growth of the pharmacovigilance market. Pharmaceutical corporations, by escalating their investment in R&D, will be able to generate innovative and advanced drugs that have superior safety profiles. Comprehensive preclinical and clinical evaluations during the drug creation procedure allow early recognition of potential safety issues, leading to the execution of proper risk reduction measures. Moreover, initiatives in R&D enhance the progression of technologies aimed at monitoring adverse events, analyzing data, and detecting signals, which makes it easier to identify adverse reactions to drugs at an early stage in the post-marketing phase. For example, the Llywodraeth Cymru Welsh Government, a government organization based in the UK, reported in February 2024 that in 2022, Wales spent £1.0 billion ($1.25 billion) on Business Expenditure on Research and Development (BERD), representing 1.9% of the UK’s total expenditure in this field. Consequently, escalated research and development activities bolstered the expansion of the pharmacovigilance market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp

How Has the Pharmacovigilance Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?

In recent times, there has been a significant expansion in the pharmacovigilance market size. It is projected to rise from a valuation of $8.58 billion in 2024 to an approximate worth of $9.73 billion in 2025, indicating a compound annual growth rate (CAGR) of 13.5%. The noteworthy growth in the historic period is a result of contributing factors such as a hike in the occurrence of adverse drug reactions (ADRs), an upsurge in research and development (R&D) endeavors, escalated rates of drug development, increased emphasis on personalized medicine, and a growing prevalence of chronic ailments.

In the coming years, the pharmacovigilance market is projected to witness speedy expansion, reaching $15.83 billion in 2029 with a compound annual growth rate (CAGR) of 12.9%. The growth over the forecast period can be traced back to surging healthcare expenditures, escalated government aid, and an aging demographic. The period also forecasts a surge in investments, adoption of artificial intelligence, implementation of novel platforms, deployment of inventive cloud-based systems, and strategic business consolidations.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5928

What Are the Key Market Innovations in thePharmacovigilance Market Over the Coming Years?

Pharmacovigilance market enterprises are emphasising the use of artificial intelligence (AI) for enhanced productivity. The integration of AI can boost the precision and effectiveness of pharmacovigilance operations, leading to improved patient treatment results. Through AI exploitation, pharmaceutical entities can optimise their procedures, augment data administration, and hasten drug development, while concurrently minimising expenses and amplifying safety. For instance, the Indian Government launched the Adverse Drug Reaction Monitoring System (ADRMS) software in August 2024, presented by the Minister of Health & Family Welfare and Minister of Chemicals and Fertilizers. This system organises the collection and assessment of adverse incidents linked with medications and medical devices, thus simplifying the reporting procedure for both consumers and medical professionals. This action significantly reinforces India’s pharmacovigilance framework by ensuring broader safety data capture and improved drug surveillance. The ADRMS aims to enhance drug safety supervision efficiency and compliance with regulations, positioning India as a pioneer in the international pharmaceutical realm.

Who Are the Top Companies Driving Innovation and Growth in thePharmacovigilance Market?

Major companies operating in the pharmacovigilance market include IQVIA, Cognizant, ICON Plc, Accenture plc, PAREXEL International Corporation., United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, Wuxi Apptec, Simcere Pharmaceutical Group, Lee’s Pharmaceutical Holdings, Luye Pharma Group, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Alcon, Secure AI Labs, OmniSol dot Tech, Canna Call Company, Veripad, Prevnos Inc., Lifescient, Inc, BeiGene, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., MSD, Novasyte, Fortrea Holdings Inc, Syneos Health Clinical, Zoetis Inc., Telerx Marketing Inc., Gilead Sciences, Inc., Elanco, Abbott Laboratories, Spimaco, Teva Pharmaceutical Industries Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

Which Key Market Segments Comprise the Pharmacovigilance Market and Drive Its Revenue Growth?

The pharmacovigilance market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining

2) By Service Provider: In-House, Contract Outsourcing

3) By Process Flow: Case Data Management, Signal Detection, Risk Management System

4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV

5) By End User: Hospitals, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals

2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies

3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs

4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies

5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=5928&type=smp

Which Regions Are Emerging as Leaders in the Pharmacovigilance Market?

North America was the largest region in the pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Pharmacovigilance Market 2025, By The Business Research Company:

Polymerase Chain Reactions (PCR) Devices, Reagents And Uses Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reactions-devices-reagents-and-uses-global-market-report

Molecular Diagnostics Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-global-market-report

Medical Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/medical-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the pharmacovigilance market size evolved in recent years?

The size of the pharmacovigilance market has seen a swift surge over the past years. The market is projected to expand from $8.58 billion in 2024 to $9.73 billion in 2025 with a compound annual growth rate (CAGR) of 13.5%. The historical growth phase has been driven by the escalating number of adverse drug reaction (ADR) cases, heightened research and development (R&D) activities, rising drug development rates, an augmented emphasis on personalized medicine, and an increasing occurrence of chronic ailments.

What are the predictions for the pharmacovigilance market size in the coming years?

In the coming years, the metal market is projected to witness consistent expansion. It is predicted to escalate to a worth of $5491.59 billion by 2029, with a compound annual growth rate (CAGR) of 4.2%. The estimated growth during the forecast period can be linked to factors such as infrastructure funding, sustainable economy efforts, resilience in the supply chain, efforts towards mitigating climate change, and geopolitical dynamics. The expected trending activities during this period encompass technological breakthroughs in metal recycling, the adoption of green solutions and renewable energy sources, advanced tech in metal processing, smart manufacturing and the move towards the ‘Industry 4.0’, along with expansion in the digital marketplace and e-commerce sector.

Get your pharmacovigilance market report here!

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

What key factors are fueling the growth of the pharmacovigilance market?

Growth in the pharmacovigilance market is being propelled by the surge in research and development initiatives. By allocating funds to R&D, pharmaceutical firms are able to create novel, safer medications. This is achieved through stringent preclinical and clinical examinations during the medication development process, which allow for potential safety risks to be discovered early on and for the necessary risk prevention tactics to be put in place. Moreover, advancements in technology for monitoring adverse events, data analysis, and signal detection, all bolstered by R&D, aid in the early identification of undesirable reactions to drugs after they have been released to the market. For example, as reported by the Llywodraeth Cymru Welsh Government agency in the UK in February 2024, Wales invested £1.0 billion ($1.25 billion) in Business Expenditure on Research and Development (BERD) in 2022. This represented 1.9% of the UK’s total expenditure in this field. As a result, the ongoing growth in research and development activities is fostering expansion in the pharmacovigilance market.

How is the global pharmacovigilance market divided into key segments?

The pharmacovigilance market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining

2) By Service Provider: In-House, Contract Outsourcing

3) By Process Flow: Case Data Management, Signal Detection, Risk Management System

4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV

5) By End User: Hospitals, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals

2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies

3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs

4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies

5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp

Who are the key firms paving the way for growth in the pharmacovigilance market?

Major companies operating in the pharmacovigilance market include IQVIA, Cognizant, ICON Plc, Accenture plc, PAREXEL International Corporation., United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, Wuxi Apptec, Simcere Pharmaceutical Group, Lee’s Pharmaceutical Holdings, Luye Pharma Group, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Alcon, Secure AI Labs, OmniSol dot Tech, Canna Call Company, Veripad, Prevnos Inc., Lifescient, Inc, BeiGene, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., MSD, Novasyte, Fortrea Holdings Inc, Syneos Health Clinical, Zoetis Inc., Telerx Marketing Inc., Gilead Sciences, Inc., Elanco, Abbott Laboratories, Spimaco, Teva Pharmaceutical Industries Ltd.

Which trends are expected to transform the pharmacovigilance market?

Pharmacovigilance market players are turning their attention to the use of Artificial Intelligence (AI) to boost their productivity levels. The application of AI enhances the efficiency and precision of pharmacovigilance tasks leading to superior patient outcomes. Pharma corporations can simplify their operations, improve data handling, and expedite drug discovery by leveraging AI, all while minimizing costs and enhancing patient safety. As an illustration, in August 2024, the Indian Government launched a pharmacovigilance software dubbed the Adverse Drug Reaction Monitoring System (ADRMS). This was unveiled by the Minister of Health & Family Welfare alongside the Minister of Chemicals and Fertilizers. The software eases the recording and examination of adverse occurrences related to medicines and medical apparatus, benefitting both healthcare providers and patients. This initiative considerably bolsters India’s pharmacovigilance framework by ensuring more inclusive safety data collection and better drug safety surveillance. The ADRMS targets enhancing drug safety management effectiveness and compliance, thereby positioning India as a trailblazer in the global pharmaceutical sector.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5928

What regions are contributing significantly to the growth of the pharmacovigilance market?

North America was the largest region in the pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Pharmaceutical Packaging Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-packaging-equipment-global-market-report

Pharmaceutical API Manufacturing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-api-manufacturing-global-market-report

Pharmaceutical Excipients Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Are the Projected Expansion Rates of the Pharmacovigilance Market for the Next Decade?

In the past few years, the pharmacovigilance market has seen a rapid expansion. The anticipated growth from $8.58 billion in 2024 to $9.73 billion in 2025, represents a compound annual growth rate (CAGR) of 13.5%. This growth, during the historical period, can be credited to various factors such as the rising frequency of adverse drug reactions (ADRs), increased research and development (R&D) endeavors, escalated drug development rates, an intensified emphasis on personalized medicine, and a growing trend in chronic diseases.

The size of the pharmacovigilance market is predicted to expand quickly in the coming years, reaching $15.83 billion by 2029 with a compound annual growth rate (CAGR) of 12.9%. Factors contributing to this growth during the projected period include increased healthcare spending, enhanced government support, and an aging population. The upcoming period is expected to witness rising investments, the adoption of artificial intelligence, utilization of inventive platforms, growth in the use of innovative cloud-based systems, and strategic partnerships and acquisitions.

What Industry-Specific Factors Are Fueling the Growth of the pharmacovigilance Market?

The escalation in research and development activities is propelling the growth of the pharmacovigilance market. Pharmaceutical companies can generate inventive drugs featuring enhanced safety profiles through substantial investment in R&D. Intense preclinical and clinical trials in the drug development phase allow for the early pinpointing of probable safety risks, giving room for appropriate risk reduction plans. Moreover, R&D ventures aid in advancing technologies for monitoring adverse events, analyzing data, and detecting signals, enabling swift identification of adverse reactions to drugs after being marketed. For instance, as per the Llywodraeth Cymru Welsh Government, a UK-based government organization, Wales injected £1.0 billion ($1.25 billion) into Business Expenditure on Research and Development (BERD) in 2022, representing 1.9% of the total UK expenditure in this field. Consequently, the rise in research and development activities is bolstering the growth of the pharmacovigilance market.

Request Your Free Pharmacovigilance Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp

Which Companies Are Redefining the Future of the Pharmacovigilance Market?

Major companies operating in the pharmacovigilance market include:

• IQVIA_x000D_

• Cognizant_x000D_

• ICON Plc_x000D_

• Accenture plc_x000D_

• PAREXEL International Corporation._x000D_

What Trends Are Poised to Drive the Future Success of the Pharmacovigilance Market?

Firms operating in the pharmacovigilance market are turning their attention towards utilizing artificial intelligence (AI) to enhance their overall efficiency. AI has the potential to increase the precision and efficiency of pharmacovigilance tasks, leading to improved patient health outcomes. By employing AI, pharmaceutical companies can refine their operations, enhance data management, and speed up the process of drug discovery, all while lowering costs and bolstering safety. For example, in August 2024, the Indian Government unveiled the Adverse Drug Reaction Monitoring System (ADRMS) software, launched by the Minister of Health & Family Welfare and Minister of Chemicals and Fertilizers. This pharmacovigilance software aids in the gathering and scrutiny of adverse events connected with medicines and medical devices, thereby simplifying the reporting process for both patients and healthcare professionals. This actionable step considerably bolsters India’s pharmacovigilance infrastructure by facilitating a more detailed acquisition of safety data and improving drug safety surveillance. The intent of the ADRMS is to elevate the efficiency of drug safety management and adherence to standards, thereby solidifying India’s status as a frontrunner in the global pharmaceutical realm.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

What Are the Major Categories and Their Growth Dynamics in the Pharmacovigilance Market?

The pharmacovigilance market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining

2) By Service Provider: In-House, Contract Outsourcing

3) By Process Flow: Case Data Management, Signal Detection, Risk Management System

4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV

5) By End User: Hospitals, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals

2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies

3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs

4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies

5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems

What Are the Leading Regions in the Pharmacovigilance Market Expansion?

North America was the largest region in the pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Core Features That Define the Pharmacovigilance Market?

Pharmacovigilance refers to the science and practices involved in the identification, evaluation, comprehension, and mitigation of side effects and other medical/vaccination-related issues. It is used to determine whether a drug’s advantages outweigh its hazards, and it doesn’t end once the drugs are approved.

Browse Through More Similar Reports By The Business Research Company:

Pharmaceutical Packaging Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-packaging-equipment-global-market-report

Pharmaceutical API Manufacturing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-api-manufacturing-global-market-report

Pharmaceutical Excipients Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-excipient-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: